LOTTE BIOLOGICS signed a Memorandum of Understanding (MOU) with Asimov, a company headquartered in Boston, Massachusetts, to collaborate in the Contract Development and Manufacturing Organization (CDMO) business. Through this agreement, LOTTE BIOLOGICS plans to leverage Asimov’s next-generation cell line development p…
BIOQuébec and Life Sciences Ontario (LSO), two leading life sciences associations, are proud to announce the signing of a Memorandum of Understanding (MOU) to enhance collaboration and foster growth across Québec and Ontario. In today’s economic climate, strengthening interprovincial partnerships is crucial to driving…
Azurity Pharmaceuticals announced the successful completion of its acquisition of Covis Group S.à r.l. ("Covis") from existing investors. With this acquisition, Covis is now a wholly-owned subsidiary of Azurity. This strategic acquisition reinforces Azurity's leadership in branded pharmaceuticals, harnessing the…
Sur-Seal, a leader in custom-engineered converting and manufacturing solutions, has acquired Kent Manufacturing LLC, a Michigan-based third generation family company with a national reputation for excellence in the custom converting industry. This strategic partnership creates a powerful platform serving the rapidly g…
Sun Pharmaceutical Industries Limited and Checkpoint Therapeutics, Inc. announced that they have entered into an agreement by which Sun Pharma will acquire Checkpoint, an immunotherapy and targeted oncology company. Checkpoint is a Nasdaq-listed commercial-stage company focused on developing novel treatments for pati…
The Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, announced a $25 million investment in its Halo Pharma facility in Whippany, New Jersey, to establish sterile injectable manufacturing capabilities, including ready-to-use syringe, cartridge, and vial …
Jazz Pharmaceuticals plc announced the companies have entered into a definitive agreement for Jazz to acquire Chimerix for $8.55 per share in cash, representing a total consideration of approximately $935 million. The transaction has been approved by both companies and is expected to close in the second quarter of 202…
Boston Scientific Corporation announced it has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS™ Intravascular Ultrasound System. An investigational technology, the TIVUS system is designed to denervate nerves surrounding blood vessels to…
The MolinaCares Accord (“MolinaCares”), in collaboration with Molina Healthcare of Nevada (“Molina”), is announcing a $1.4 million commitment to improve access to care in Nevada. This latest investment builds on Molina’s $2.8 million commitment in 2024 that supported 29 community-based organizations and providers, bri…
This initiative aims to produce eco-friendly bio-based molecules from low-cost, eco-friendly sources. Key benefits include: Cost-parity with conventional methods: Unlike existing bio-based molecules production, this initiative aims to achieve cost-parity with conventional processes by utilising low-cost renewable sou…
Page 36 of 37